Neopharmed Gentili is an Italian pharma manufacturer focused on high-value therapeutic solutions across multiple disease areas. The hiring mix is sales-heavy (11 of 18 open roles in sales), paired with active infrastructure projects around hybrid cloud (Azure + AWS + on-premise) and backup/disaster recovery — typical of a mid-sized manufacturer scaling commercial footprint while modernizing IT operations to support growth.
Neopharmed Gentili develops, manufactures, and commercializes pharmaceutical products for patients across multiple therapeutic areas. Founded in 2018 and based in Milan, the company operates across Italy with a network of over 400 employees. The product strategy includes both branded and generic-equivalent offerings, with current commercial focus on promoting drug and product lists through marketing and sales channel expansion. Infrastructure runs on a hybrid foundation (Azure, AWS, on-premise VMware), with active work on disaster recovery planning and cloud-to-on-premise integration.
Core infrastructure: Azure, AWS, VMware vSphere, Windows, Linux. Networking: Cisco, Fortinet. Backup and data protection: Veeam, Commvault. Administration tools: PowerShell, SAP, Microsoft Office.
Milan (Milano), Italy. The company was founded in 2018 and currently employs 201–500 people across the country.
Other companies in the same industry, closest in size